Apyx Medical (APYX) director nets 6,976 shares from 12,000-option exercise and share withholding
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Apyx Medical Corp director Lawrence Waldman reported a routine stock option exercise with tax withholding. On June 30, 2026, a Spousal Lifetime Access Trust associated with him exercised 12,000 stock options at an exercise price of $1.88 per share. Under the net exercise terms, 5,024 shares that would have been issued were instead withheld by the company at a value of $4.49 per share to cover the aggregate exercise price, and 6,976 net shares were issued. Following these transactions, the filing shows 37,563 common shares held directly and 12,314 shares held indirectly through the trust, while the exercised option grant was reduced to zero. The footnotes state the trust is a Spousal Lifetime Access Trust and that Waldman disclaims beneficial ownership of its holdings except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
12,000 shares exercised/converted
Mixed
4 txns
Insider
Waldman Lawrence
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock option (right to buy) | 12,000 | $0.00 | -- |
| Exercise | Common Stock | 12,000 | $1.88 | $23K |
| Tax Withholding | Common Stock | 5,024 | $4.49 | $23K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock option (right to buy) — 0 shares (Indirect, By SLAT);
Common Stock — 17,338 shares (Indirect, By SLAT);
Common Stock — 37,563 shares (Direct, null)
Footnotes (1)
- Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person.
Key Figures
Options exercised: 12,000 shares
Option exercise price: $1.88 per share
Shares withheld: 5,024 shares at $4.49
+4 more
7 metrics
Options exercised
12,000 shares
Stock options exercised on June 30, 2026
Option exercise price
$1.88 per share
Exercise price for 12,000 stock options
Shares withheld
5,024 shares at $4.49
Shares withheld to satisfy aggregate exercise price
Net shares issued
6,976 shares
Net common shares issued after net exercise
Direct holdings after transaction
37,563 shares
Common stock held directly following transactions
Indirect trust holdings after transaction
12,314 shares
Common stock held indirectly by SLAT following transactions
Option expiration date
July 28, 2026
Expiration date of stock option grant that was exercised
Key Terms
Spousal Lifetime Access Trust, net exercise, pecuniary interest, Section 16, +1 more
5 terms
Spousal Lifetime Access Trust financial
"Held by a Spousal Lifetime Access Trust (the "SLAT")."
net exercise financial
"On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options"
pecuniary interest financial
"except to the extent of the Reporting Person's pecuniary interest therein, if any."
Section 16 regulatory
"beneficial owner of such securities for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
FAQ
What insider transaction did Apyx Medical (APYX) director Lawrence Waldman report?
Apyx Medical director Lawrence Waldman reported a net exercise of 12,000 stock options. The options had a $1.88 per share exercise price, resulting in 6,976 net shares issued after the issuer withheld shares to cover the aggregate exercise price.
How many Apyx Medical (APYX) options did the trust associated with Waldman exercise?
The Spousal Lifetime Access Trust associated with Lawrence Waldman exercised 12,000 stock options. These options carried an exercise price of $1.88 per share, and the exercise was structured as a net share settlement rather than a cash payment to the company.
How were taxes or exercise costs satisfied in this Apyx Medical (APYX) Form 4?
The exercise costs were satisfied by withholding 5,024 shares otherwise issuable on exercise. Those shares were valued at $4.49 per share, and this tax-withholding disposition avoided a separate cash payment by using part of the option shares to cover the aggregate exercise price.